| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000040444 |
| Receipt No. | R000046156 |
| Scientific Title | Development of a new system for evaluating visual function in diabetic retinopathy using EvokeDx |
| Date of disclosure of the study information | 2020/05/20 |
| Last modified on | 2021/06/02 (Ver. 2) |
| Basic information | ||
| Public title | Development of a new system for evaluating visual function in diabetic retinopathy using EvokeDx | |
| Acronym | DREX Study | |
| Scientific Title | Development of a new system for evaluating visual function in diabetic retinopathy using EvokeDx | |
| Scientific Title:Acronym | DREX Study | |
| Region |
|
|
| Condition | ||
| Condition | diabetic retinopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Development of a new system for evaluating visual function in diabetic retinopathy using EvokeDx |
| Basic objectives2 | Others |
| Basic objectives -Others | To evaluate the relationship between the grade of diabetic retinopathy and visual function. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual function measured by EvokeDx |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy adults and Diabetic patients who have best-corrected visual acuity better than 0.7 in decimal. | |||
| Key exclusion criteria | Patients with diabetic macular edema, galucoma, and who had been treated diabetic retinopathy within 12 weeks. If the researchers found the person not suitable for the study, the person will be excluded from the study. | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | St Luke's International Hospital | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | 1048560 | ||||||
| Address | 9-1 Akashicho Chuoku Tokyo Japan | ||||||
| TEL | 03-3451-5151 | ||||||
| ozaway@luke.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | St Luke's International Hospital | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | 1048560 | ||||||
| Address | 9-1 Akashicho Chuoku Tokyo Japan | ||||||
| TEL | 03-3451-5151 | ||||||
| Homepage URL | |||||||
| ozaway@luke.ac.jp | |||||||
| Sponsor | |
| Institute | St Luke's International University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SENJU PHARMACEUTICAL CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee of St Luke's International Hospital |
| Address | 9-1 Akashicho Chuoku Tokyo Japan |
| Tel | 03-3451-5151 |
| kenkyukikaku@luke.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | NONE |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046156 |